Access to medicine transforms lives.</br>Join us on a mission to reach 8 billion. | Access to Medicine

Invest in access

Access to medicine should not depend on where someone lives. Help make access equitable for all.

News

Read the latest at the Foundation

Tools to fight AMR exist, but industry-wide action is needed to tilt the battle against superbugs

2026 Index Methodology zeroes in on scalable actions capable of delivering lasting impact for more people

Briefing for the UN General Assembly 2026

How can governments steer pharmaceutical industry behaviour toward equitable access in the context of the UN High-Level Meeting?

Research hub

Explore our research reports and publications

Access to diabetes care for children and young people: Pharma companies' current actions and opportunities ahead

Featured Research

2024 Access to Medicine Index

19 November 2024

Patient centricity: How is the pharma industry addressing patient reach?

10 September 2024

2026 AMR Benchmark

Learn what's at stake and why action matters

Events and engagements

Sharing our insights to help drive change

Steffi Van Uytfanghe to present insights on medical oxygen access gaps at 2026 Gasworld’s Global Industrial Gas Conference

02 December 2026

UBS and Neuberger Berman to co-host investor launch events for the tenth Access to Medicine Index

10 November 2026

Foundation to co-host Health Equity Event focused on patient reach alongside PRI in Person 2026

14 October 2026

Achieving equitable access to infectious diseases diagnostics: Learnings and pathways forward – Meeting Report

Access insights

Read our analyses of critical developments in the pharmaceutical industry

Commentary: Merck & Co. commits to broadening access to HIV prevention in LMICs

Commentary: MPP and Roche move to expand access to influenza treatment in LMICs

Emerging markets as a growth opportunity for pharmaceutical companies